BeiGene’s biologics manufacturing facility in Guangzhou, China, is a testament to cutting-edge biopharmaceutical production. STAND Structural Engineering played a key role in designing this massive complex, which includes over 1 million square feet of space dedicated to the development and manufacturing of life-saving cancer treatments. The facility boasts advanced technologies such as 3D modeling, digital twin simulation, and AI integration for optimal efficiency and quality control. It’s designed to meet the stringent good manufacturing practices (cGMP) of global regulatory agencies like the FDA, NMPA, and EMA. This project marks a significant step forward in BeiGene’s mission to provide affordable and innovative cancer therapies worldwide.
